Hans Orlent, Hans

dr. Hans Orlent

Maag-, Darm- en Leverziekten

Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C).

SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials. P110-114.
» http://www.ncbi.nlm.nih.gov/pubmed/

Versant HCV Genotype 2.0 assay (LiPA) misclassifies the circulating HCV recombinant RF1_2k/1b in genotype 2 patients.

Hepatology, 2016; 64, S1: A821.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Versant hcv genotype 2.0 line probe assay (lipa) misclassifies the circulating hcv recombinant rf1_2k/1b in genotype 2 patients .

Acta Gastroenterol Belg 2016;79(1): A36.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in Belgium: comparison with monoinfected patients and impact of hepatitis C virus replication.

Acta Gastroenterol Belg 2016;79(1): A33.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Acta Gastroenterol Belg 2016;79(1): A08.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Light-to-moderate alcohol intake increases the risk of hepatocellular carcinoma in patients with hcv-related compensated cirrhosis: a prospective study.

Acta Gastroenterol Belg 2016;79(1): A01.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

Gastroenterology 2016;150:903-10 e8.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.

JIMD reports 2016;25:77-81.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Eikenella corrodens perinephric abscess due to pancreatic fistula in chronic pancreatitis.

Case report and literature review. Acta Gastroenterol Belg 2016; accepted.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.

01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

International journal of molecular sciences 2016;17.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

“Heads or tails: genotyping of Hepatitis C Virus concerning the 2k/1b circulating recombinant form”.

International Journal of Molecular Sciences (Int J Mol Sci) 2016, 17(9),1384; doi:10.3390/ijms17091384
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Sofosbuvir in combination with Simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Hepatology 2015;62, 1 (Suppl): A1091
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Efficacy, safety and pharmacokinetics of 12 weeks of simeprevir in combination with tmc647055, ritonavir and jnj-56914845 in genotype 1 hepatitis c virus-infected patients.

APASL 2015.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

A high number of advanced adenomas are found in individuals referred from the Flemish colon cancer screening program : a prospective single center quality registry.

Acta Gastroenterologica Belg 2015;78(1): A 105.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Acta Gastroenterologica Belg 2015; 78(1): A 29.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

High-dose (peg)interferon therapy in treatment-naive, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015;47:87-8.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Hepatology, Suppl 2014, 60, S1: A141.
01/01/2014

» http://www.ncbi.nlm.nih.gov/pubmed/

High-dose (peg)interferon therapy in treatmentnaïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and Liver Disease 2014.
01/01/2014

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Treatment of Chronic Hepatitis C Genotype 1 with Protease inhibitors: implications for the laboratory of molecular biology.

Noso Info. 2013, XVII (1):13-18.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report.

Hepatology research : the official journal of the Japan Society of Hepatology 2013;43:991-8.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-742
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-259
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-2; author reply 2-3.
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Belgian Association for the Study of the L. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-59.
01/01//2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 75, 245-259
01.01.2012

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

J Hepatol 2011, S: A54.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Steering Committee of the Belgian Association for the Study of the L. High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT.

Results of the Belgian NAFLD registry. Acta Gastroenterol Belg 2011;74:9-16.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Belgian Association for the Study of the L. IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

Acta Gastroenterol Belg 2011;74:317-22.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Transpl Int 2011;24:e30-4.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.

Acta Gastroenterol Belg 2011;74(1):9-16
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver.

Acta Gastroenterol Belg 2011;74(1): A21
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J. Hepatol accepted
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B-delta virus co-infection in Belgium: a multicenter BASL study. Prospective epidemiology and comparison to HBV mono-infection.

Acta Gastroenterol Belg Volume: in press
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Progressive multifocal leucoencephalopathy in liver transplant recipents: a case report and review of the literature.

Transplant International 2011;24e30-4.doi:10.1111/j.1432-2277.2010.01190x
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

Acta Gastroenterol Belg 2011;74(1): A21
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

J Hepatology; 2010, S276.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

Acta Gastroenterol Belg; 2010;73(1), A97.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

Eur J Gastroenterol Hepatol 2010;22:1253-9.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.

Eur J Gastroenterol Hepatol 2010;22:1443-8.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

Eur J Gastroenterol Hepatol 2010;22:494-9.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Falk workshop. Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C). SNMC in interferon non-responders with chronic hepatitis C

European experience in controlled trials. P110-114.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

Eur J Gastroenterol Hepatol 2010;22(4):494-9
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Eur J Gastroenterol Hepatol 2010:in press.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

Eur J Gastroenterol Hepatol 2010;22(10):1253-9.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Asian-Pacific Association for the Study of the Liver Meeting 2009, Hong Kong. Hepatitis B-Delta Virus Co-Infection in Belgium: Preliminary Data of the BASL HDV Registr.

Hong Kong, China, Hepatology International, 3(1), 200-201, abstract PE470
01.01.2009

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

Hepatology Suppl 2009: A493
01.01.2009

» http://www.ncbi.nlm.nih.gov/sites/

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

J Magn Reson Imaging 2008;27:117-24.
01/01/2008

» http://www.ncbi.nlm.nih.gov/pubmed/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Hepatology, Suppl 2008: A1236
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

JMRI 2008;27:117-24
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Société Royale Belge de Gastro 13 October 2007: Traitements émergents en hépatogastroentérologie: comment les rendre accessibles à la pratique en Belgique?: Moderator.

Société Royale Belge de Gastro 13 October 2007
13.10.2007

» http://www.ncbi.nlm.nih.gov/sites/

Belgian Association for the Study of the L. Management and treatment of chronic hepatitis B virus

Belgian Association for the Study of the Liver (BASL) 2007 guidelines. Acta Gastroenterol Belg 2007;70:389-420.
01/01/2007

» http://www.ncbi.nlm.nih.gov/pubmed/

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology 2007;132:15-6, 467-8.
01/01/2007

» http://www.ncbi.nlm.nih.gov/pubmed/

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology. 2007;132:15-6, 467-8
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

Acta Gastroenterol Belg 2007;70:389-420.
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients. AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis. (Atlanta, USA 07-09.09.2006)

Atlanta, USA;Abstract in abstract-book
07.09.2006

» http://www.ncbi.nlm.nih.gov/sites/

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38:82-5.
01/01/2006

» http://www.ncbi.nlm.nih.gov/pubmed/

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

J Hepatol 2006;45:539-46.
01/01/2006

» http://www.ncbi.nlm.nih.gov/pubmed/

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients.

AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis. Atlanta, 07-09.09.2006. Poster. Abstract in abstract-book.
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

J Hepatol 2006;45(4):539-46.
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38(1):82-5
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Dig Dis Sci 2005;50:1804-6.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST.

Ned Tijdschr Geneeskd 2005;149:2807-9.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Steering Committee of the Belgian Association for the Study of the L. The management of patients with mild hepatitis C.

Acta Gastroenterol Belg 2005;68:314-8.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST

Ned Tijdschr Geneeskd 2005;149(50):2807-9
01.01.2005

» http://www.ncbi.nlm.nih.gov/sites/

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Dig Dis Sci 2005;50(10):1804-6
01.01.2005

» http://www.ncbi.nlm.nih.gov/sites/

BASL winter meeting 2004: Peginterferon and dose-titrated ribavirin for hepatitis C associated nephrotic membranoproliferative glomerulonephritis.

BASL
01.01.2004

» http://www.ncbi.nlm.nih.gov/sites/

Glycyrrhizin given as Stronger Neo-Minophagen C (SNMC) for the treatment of chronic hepatitis C: biochemical and histological effects after 26 weeks of treatment.

Hepatology, Suppl 2003(38): A340
01.01.2003

» http://www.ncbi.nlm.nih.gov/sites/

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant.

Transplant 2003;32(1):115-7.
01.01.2003

» http://www.ncbi.nlm.nih.gov/sites/
Toon meer